Linefor

Pregabalin, the active ingredient in Linefor, is a gabapentinoid presented as an oral tablet for oral use. It is prescribed to manage neuropathic pain, partial seizures, generalized anxiety disorder, and fibromyalgia in adult patients. The medication works by modulating calcium channel activity to reduce neuronal excitability.

GNH USA supplies Linefor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across markets.

Pregabalin is indicated for several central nervous system disorders that involve abnormal neuronal excitability.

- Neuropathic pain: Reduces pain intensity and improves functional ability in diabetic peripheral neuropathy and post‑herpetic neuralgia. - Partial seizures: Lowers the frequency and severity of focal onset seizures in adult patients with epilepsy. - Generalized anxiety disorder: Mitigates excessive worry, tension and associated physical symptoms, enhancing daily functioning in adults. - Fibromyalgia: Alleviates widespread musculoskeletal pain, fatigue and sleep disturbances, leading to better quality of life.

Pregabalin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness - Somnolence - Peripheral edema - Weight gain - Blurred vision

Serious or Rare Side Effects: - Angioedema - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Suicidal thoughts or behavior

When prescribing Linefor, clinicians should consider several safety aspects.

- Renal impairment: Adjust dose or monitor closely in patients with reduced kidney function. - Cardiovascular disease: Use cautiously in patients with heart failure or arrhythmias. - Elderly: Increased risk of falls and sedation; start at lower dose. - Concomitant CNS depressants: May enhance drowsiness; avoid alcohol. - Pregnancy and lactation: Safety not established; discuss risks with healthcare provider. - Store at ambient temperature: Keep below 25 °C, in original packaging, protected from moisture and light.

Pregabalin can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Opioids: Combined use can cause profound respiratory depression and sedation. - CNS depressants (benzodiazepines, barbiturates): Heightened risk of severe drowsiness and impaired coordination. - Antihypertensives: May enhance hypotensive effects.

Moderate Interactions (Monitor Closely): - Diuretics: Can increase risk of peripheral edema. - ACE inhibitors or ARBs: May affect renal function when combined. - Anticholinergic agents: May worsen cognitive impairment.